These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 11017137)

  • 1. VEGF gene therapy: stimulating angiogenesis or angioma-genesis?
    Carmeliet P
    Nat Med; 2000 Oct; 6(10):1102-3. PubMed ID: 11017137
    [No Abstract]   [Full Text] [Related]  

  • 2. Peptides encoded by exon 6 of VEGF inhibit endothelial cell biological responses and angiogenesis induced by VEGF.
    Jia H; Jezequel S; Löhr M; Shaikh S; Davis D; Soker S; Selwood D; Zachary I
    Biochem Biophys Res Commun; 2001 Apr; 283(1):164-73. PubMed ID: 11322784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease: a phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermittent claudication.
    Rajagopalan S; Mohler ER; Lederman RJ; Mendelsohn FO; Saucedo JF; Goldman CK; Blebea J; Macko J; Kessler PD; Rasmussen HS; Annex BH
    Circulation; 2003 Oct; 108(16):1933-8. PubMed ID: 14504183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular endothelial growth factor (VEGF) and its effect on angiogenesis.
    Jośko J; Gwóźdź B; Jedrzejowska-Szypułka H; Hendryk S
    Med Sci Monit; 2000; 6(5):1047-52. PubMed ID: 11208453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracavernosal vascular endothelial growth factor (VEGF) injection and adeno-associated virus-mediated VEGF gene therapy prevent and reverse venogenic erectile dysfunction in rats.
    Rogers RS; Graziottin TM; Lin CS; Kan YW; Lue TF
    Int J Impot Res; 2003 Feb; 15(1):26-37. PubMed ID: 12605238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Vascular endothelial growth factor--fundamental research and experimental study in plastic surgery].
    Huang CY; Shen ZY
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2002 Jan; 16(1):64-9. PubMed ID: 11826659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adeno-associated viral vector-mediated vascular endothelial growth factor gene transfer induces neovascular formation in ischemic heart.
    Su H; Lu R; Kan YW
    Proc Natl Acad Sci U S A; 2000 Dec; 97(25):13801-6. PubMed ID: 11095751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Vascular endothelial growth factor and its application in therapy of cardiovascular diseases].
    Kowalczyk J; Pasyk S
    Pol Merkur Lekarski; 2002 Jul; 13(73):74-8. PubMed ID: 12362514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-4 inhibits the vascular endothelial growth factor- and basic fibroblast growth factor-induced angiogenesis in vitro.
    Lee IY; Kim J; Ko EM; Jeoung EJ; Kwon YG; Choe J
    Mol Cells; 2002 Aug; 14(1):115-21. PubMed ID: 12243340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VEGF is deposited in the subepithelial matrix at the leading edge of branching airways and stimulates neovascularization in the murine embryonic lung.
    Healy AM; Morgenthau L; Zhu X; Farber HW; Cardoso WV
    Dev Dyn; 2000 Nov; 219(3):341-52. PubMed ID: 11066091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leaky vessels? Call Ang1!
    Jain RK; Munn LL
    Nat Med; 2000 Feb; 6(2):131-2. PubMed ID: 10655092
    [No Abstract]   [Full Text] [Related]  

  • 12. [Therapeutic angiogenesis for ischemic heart disease by transplantation of bone marrow cells].
    Matsubara H
    Nihon Rinsho; 2003 Apr; 61 Suppl 4():698-703. PubMed ID: 12735052
    [No Abstract]   [Full Text] [Related]  

  • 13. Too many vessels? Not enough? The wrong kind? The VEGF debate continues.
    Ware JA
    Nat Med; 2001 Apr; 7(4):403-4. PubMed ID: 11283656
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficient expression of the vascular endothelial growth factor gene in vitro and in vivo, using an adeno-associated virus vector.
    Byun J; Heard JM; Huh JE; Park SJ; Jung EA; Jeong JO; Gwon HC; Kim DK
    J Mol Cell Cardiol; 2001 Feb; 33(2):295-305. PubMed ID: 11162134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ex vivo expression of angiogenic growth factors and their receptors in human penile cavernosal cells.
    Rajasekaran M; Kasyan A; Allilain W; Monga M
    J Androl; 2003; 24(1):85-90. PubMed ID: 12514088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin II type 2 receptor inhibits vascular endothelial growth factor-induced migration and in vitro tube formation of human endothelial cells.
    Benndorf R; Böger RH; Ergün S; Steenpass A; Wieland T
    Circ Res; 2003 Sep; 93(5):438-47. PubMed ID: 12881481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapeutic angiogenesis awakens hope. New blood vessels for arterial occlusive disease patients? (interview by Dr. Judith Neumaier)].
    Diehm C
    MMW Fortschr Med; 2002 Jul; 144(27-28):14. PubMed ID: 12198872
    [No Abstract]   [Full Text] [Related]  

  • 18. Vascular endothelial growth factor (VEGF) receptor-2 antagonists inhibit VEGF- and basic fibroblast growth factor-induced angiogenesis in vivo and in vitro.
    Tille JC; Wood J; Mandriota SJ; Schnell C; Ferrari S; Mestan J; Zhu Z; Witte L; Pepper MS
    J Pharmacol Exp Ther; 2001 Dec; 299(3):1073-85. PubMed ID: 11714897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular endothelial growth factor and the regulation of angiogenesis.
    Ferrara N
    Recent Prog Horm Res; 2000; 55():15-35; discussion 35-6. PubMed ID: 11036931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VEGF spatially directs angiogenesis during metanephric development in vitro.
    Tufró A
    Dev Biol; 2000 Nov; 227(2):558-66. PubMed ID: 11071774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.